Finally, chromosomal amplifications or activating mutations of the receptor tyrosine kinase KIT are found in 5–10% of cutaneous melanomas and confer independence from external growth factors, thus representing the most-upstream source of RAS pathway hyperactivation. Here, KIT is linked to cutaneous melanoma.